We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
ONK Therapeutics has announced a new collaboration with blood cancer charity Antony Nolan, with the aim of accelerating the development of next-generation natural killer (NK) cell therapies.